PET/CT Shows Clear Advantages Over Conventional Staging For Patients With Locally Adv

[News]

New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-fludeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging offers significant prognostic stratification information at initial staging for patients with locally advanced breast cancer...

More... (http://www.medicalnewstoday.com/releases/254554.php)